# SPR Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spr-therapeutics

- Industry: Medical Devices & Equipment
- Headquarters: Cleveland, US
- Total disclosed funding: $76M
- Latest round: Series D (Jan 30, 2024)
- Investors on record: 6

## About

Founded in 2010 by Geoffrey Thrope and Maria E. Bennett, and based in Ohio, US, SPR Therapeutics, Inc. is a medical device company that develops and offers minimally invasive treatment for managing chronic and acute pain. In February 2024, SPR Therapeutics, Inc. raised USD 60 million in venture debt funding from investor SLR Capital Partners.

SPR Therapeutics offers the SPRINT® Peripheral Nerve Stimulation (PNS) System, a system designed for short-term use, and does not involve permanent implants. It features components such as a small, coiled lead, a percutaneous introducer, a pulse generator with rechargeable batteries, and a hand-held remote for patient control. The SPRINT PNS System targets various types of pain, including low back, shoulder, knee, post-amputation, and postoperative pain. 

The company intends to use the February 2024 funding to broaden the market presence of the Sprint PNS System.

## Funding rounds

- Series D, Jan 30, 2024, $26M — RC Capital, Revelation Partners, Mutual Capital Partners
- Series D, Aug 20, 2021, $20M — RC Capital, Mutual Capital Partners, Revelation Partners
- Series C, Sep 12, 2017, $25M — Frontcourt Ventures
- Series A, Jan 8, 2013, $5M — Western Reserve Products, NDI Medical

## Investors

- Western Reserve Products — Series A
- NDI Medical (https://capitalatlas.ai/funds/ndi-medical) — Series A
- Frontcourt Ventures (https://capitalatlas.ai/funds/frontcourt-ventures) — Series C
- RC Capital (https://capitalatlas.ai/funds/rc-capital) — Series D
- Mutual Capital Partners (https://capitalatlas.ai/funds/mutual-capital-partners) — Series D
- Revelation Partners (https://capitalatlas.ai/funds/revelation-partners) — Series D